Patients transitioning from another GLP-1 platform should document their existing treatment history including current medication, dose, duration, and clinical response in the intake
This is especially relevant for people taking anticoagulants, immune-modulating medications, or multiple prescription drugs
Some doctors may prescribe semaglutide or a high dose of liraglutide to those classified as overweight rather than obese or if they have other health conditions that are preventing them from losing weight
Available online: [PubMed] [Google Scholar] 23.Won H., Cho J.Y., Lee S
Since weight loss is relatively rapid, the structure of the skin and deep facial tissues does not have time to restructure and shrink, leaving the overlying tissue and skin with increased laxity, volume loss, and more wrinkles
A meta-analysis of 5 trials (n=20,387) estimated that SGLT2i use in people with advanced diabetic kidney disease reduced the risk of kidney failure by 31% (HR 0.69, 95% CI 0.57 to 0.83) [58] Note that this is over and above the effect of both BP control and use of RAASis
